THE DILEMMA OF USE OF THE LEVOTHYROXIN IN PATIENTS WITH HEART FAILURE (literature review and own data)
DOI:
https://doi.org/10.21856/j-PEP.2023.2.10Keywords:
heart failure, levothyroxine, hypothyreosis, left ventricular engect fraction, course of deseaseAbstract
Systematization of literature data on the use of thyroid hormones in patients with heart failure and the results of own research are given.
The therapy of levothyroxine in patients with heart failure, at the moment of time, remains still an "open book". Several questions remain unsolved: regimen, doses and schedule of levothyroxine use, consequences of this therapy. It is necessary to conduct large, multicenter, prospective, placebo-controlled studies, which should provide information on the safety and impact of levothyroxine on the long-term prognosis of these patients.
Our study shows that the long-term administration of levothyroxine in patients with heart failure and accompanying hypothyroidism has a dose-dependent positive effect on the value of the left ventricular ejection fraction and on the course of heart pathology. The maximum ejection fraction of the left ventricle is observed in patients who took the drug in a dose > 1.2 μg/kg. The use of the drug in a dose > 0.53 μg/kg leads to a probable decrease in the frequency of re-hospitalization within 2 years due to decompensation of heart failure.
References
Gerdes AM, Iervasi G. Circulation 2010;122(4): 385-393. https://doi.org/10.1161/CIRCULATIONAHA.109.917922
Pantos C, Malliopoulou V, Paizis I, et al. Mol Cell Biochem 2003;242: 173-180.
Pantos C, Mourouzis I, Cokkinos DV. Heart Fail Rev 2010;15: 143-154. https://doi.org/10.1007/s10741-008-9111-0
Pantos C, Mourouzis I, Markakis K, et al. Eur J Cardiothorac Surg 2007;32: 333-339. https://doi.org/10.1016/j.ejcts.2007.05.004
Pantos C, Mourouzis I, Markakis K, et al. Basic Res Cardiol 2008;103: 308-318. https://doi.org/10.1007/s00395-008-0697-0
Pantos CI, Malliopoulou VA, Mourouzis IS, et al. Thyroid 2002;12: 325-329. https://doi.org/10.1089/10507250252949469
Khalife WI, Tang YD, Kuzman JA, et al. Am J Physiol Heart Circ Physiol 2005;289: H2409-H2415. https://doi.org/10.1152/ajpheart.00483.2005
Kuzman JA, Tang Y, Vogelsang KA, Said S. Can J Physiol Pharmacol 2007;85: 311-318. https://doi.org/10.1139/y07-011
Liu Y, Redetzke RA, Said S, et al. Am J Physiol Heart Circ Physiol 2008;294: H2137-H2143. https://doi.org/10.1152/ajpheart.01379.2007
Kinugawa K, Yonekura K, Ribeiro RC, et al. Circ Res 2001;89: 591-598. https://doi.org/10.1161/hh1901.096706
Tang YD, Kuzman JA, Said S, et al. Circulation 2005;112: 3122-3130. https://doi.org/10.1161/circulationaha.105.572883
Thomas TA, Kuzman JA, Anderson BE, et al. Am J Physiol Heart Circ Physiol 2005;288: H2118-H2122. https://doi.org/10.1152/ajpheart.01000.2004
Iervasi G, Nicolini G. Intern Emerg Med 2013;Suppl: 1-4. https://doi.org/10.1007/s11739-013-0911-4
Silva JE, Braverman LE, Utiger RD. Philadelphia 2000: 642-651.
Kim B, Carvalho-Bianco SD, Larsen PR. Arq Bras Endocrinol Metab 2004;1(48): 43-51. https://doi.org/10.1590/s0004-27302004000100019
Hoit BD, Khoury SF, Shao Y, et al. Circulation 1997;96: 592-598. https://doi.org/10.1161/01.CIR.96.2.592
Novotny J, Bourova L, Malkova O, et al. J Mol Cell Cardiol 1999;31: 761-772. https://doi.org/10.1006/jmcc.1998.0913
Heubach JF, Trebess I, Wettwer E, et al. Cardiovasc Res 1999;42: 173-182. https://doi.org/10.1016/S0008-6363(98)00262-4
Zolk O, Kilter H, Flesch M, et al. Biochem Biophys Res Commun 1998;248: 801-805. https://doi.org/10.1006/bbrc.1998.9030
Carvalho-Bianco K, Larsen R. Arq Bras Endocrinol Metab 2004;48(1): 171-175. https://doi.org/10.1590/S0004-27302004000100019
Iervasi G, Emdin M, Colzani RMP, et al. New Trends in Research, Diagnosis and Treatment : Second International Congress on Heart Disease, Englewood, 2001: 549-553
Moruzzi P, Doria E, Agostoni PG. Am J Med 1996;101: 461-467. https://doi.org/10.1016/s0002-9343(96)00281-1
Novitzky D. Thyroid 1996;6: 531-536. https://doi.org/10.1089/thy.1996.6.531
Portman MA, Fearneyhough C, Ning XH, et al. J Thorac Cardiovasc Surg 2000;120: 604-608. https://doi.org/10.1067/mtc.2000.108900
Ranasinghe AM, Quinn DW, Pagano D, et al. Circulation 2006;114(suppl): I-245-I-250. https://doi.org/10.1161/circulationaha.105.000786
Klein I, Danzi S. Circulation 2007;116(15): 1725-1735. https://doi.org/10.1161/circulationaha.106.678326
Ito K, Kagaya Y, Shimokawa H. Vascul Pharmacol 2010;52: 138-141. https://doi.org/10.1016/j.vph.2009.10.004
Goldman S, McCarren M, Morkin E, et al. Circulation 2009;119: 3093-3100. https://doi.org/10.1161/CIRCULATIONAHA.108.834424
Malik FS, Mehra MR, Uber PA, Park MH. J Card Fail 1999;5: 31-37. https://doi.org/10.1016/s1071-9164(99)90022-2
Pingitore A, Galli E, Barison A, et al. J Clin Endocrinol Metab 2008;93: 1351-1358. https://doi.org/10.1210/jc.2007-2210
Ripoli A, Pingitore A, Favilli B, et al. J Am Coll Cardiol 2005;45: 439-445. https://doi.org/10.1016/j.jacc.2004.10.044
Klemperer JD, Klein IL, Ojamaa K. Ann Thorac Surg 1996;61: 1323-1327. https://doi.org/10.1016/0003-4975(96)00102-6
Novitzky D, Fontanet H, Snyder M. Cardiology 1996;87: 509-555. https://doi.org/10.1159/000177147
Brokhin M, Klein I. Clin Cornerstone 2005;7: S28-S29. https://doi.org/10.1016/S1098-3597(05)80057-2
Ponikowski P, Voors AA, Anker SD, et al. Eur Heart J 2016;8: 123. https://doi.org/10.1093/eurheartj/ehw128
The coronary drug project research group. JAMA 1972;220: 996-1008.
Zhang Y, Dedkov E, Lee B, et al. J Card Fail 2014;12: 1012-1019. https://doi.org/10.1016/j.cardfail.2014.10.003
Pyvovar SM. Optimisation of prognosis of the clinical outcome and effectiveness of heart failure treatment in patients with coronary artery disease with concomitant thyroid pathology : The qualifying thesis as a manuscript. Thesis for the Degree of Doctor of Medical Sciences, Kharkiv, 2021 : 383 p.
Pyvovar SM, Rudyk IS, Lozyk TV, et al. Probl Endocrine Pathol 2020;1(71): 58-64. https://doi.org/10.21856/j-PEP.2020.1.08
Brian DH, Saeb FK, Yanfu S, et al. Circulation 1997;96: 592-598. https://doi.org/10.1161/01.CIR.96.2.592
Dillmann WH. Thyroid 2002;12: 447-452. https://doi.org/10.1089/105072502760143809
Hesse C, Eisenach JH. Curr Pharmacogenomics Person Med 2008;6(3): 160-170. http://dx.doi.org/10.2174/1875692110806030160
Pyvovar SM, Rudyk YS, Lozyk TV, et al. Herald Probl Biol Med 2020;4(2);(154): 181-188. https://doi.org/10.31718/mep.2019.23.5-6.05
Xiao RP. Sci STKE 2001;2001(104): re15. https://doi.org/10.1126/stke.2001.104.re15
Zhu WZ, Zheng M, Koch WJ, et al. Proc Natl Acad Sci USA 2001;98: 1607-1612. https://doi.org/10.1073/pnas.98.4.1607
ISSN 
ISSN 
